2 publications

• Published Subscription 27 Jul 2023

  RECENT STUDIES OF DRUGS IN TUBERCULOSIS

  By K. Shanmugapriya, Dr.S. Kameshwaran, S. Shameem, A. Saranya, S.M. Shabariraj, K.P. Sathish

  Abstract: The infectious disease tuberculosis (TB), which is brought on by a particular type of bacteria, typically affects the lungs. When infected individuals cough, sneeze, or spit, the virus is disseminated through the air. There are ways to prevent and treat tuberculosis. According to estimates, the TB pathogen has infected around a quarter of the world's population. A cough that lasts longer than three weeks, together with the possibility of phlegm …

  Published in Research & Reviews: A Journal of Drug Design & Discovery · Vol. 10, Issue 1, 2023 · pp. 14–22 Read article →

• Published Subscription 26 Jul 2023

  REVIEW ON PICK´S DISEASE

  By K. Shanmugapriya, Dr.S. Kameshwaran, S. Shameem, K.P. Sathish, A. Saranya

  Abstract: Pick´s disease is a serious clinicopathological condition that causes the frontotemporal lobe to atrophy circumferentially. Frontotemporal lobar degeneration (FTLD) is now the clinical diagnosis for patients with dementia who have frontotemporal atrophy. FTLD with TDP-43-positive inclusions, corticobasal degeneration, progressive supranuclear palsy, basophilic inclusion body disease, neuronal intermediate filament inclusion disease, and argyrophilic grain disease are additional underlying diseases in FTLD patients.

  Published in Research and Reviews: A Journal of Pharmaceutical Science · Vol. 14, Issue 1, 2023 · pp. 34–41 Read article →